These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18251066)

  • 21. [NT-proBNP in practice: from chemistry to medicine].
    Jourdain P; Lefèvre G; Oddoze C; Sapin V; Dievart F; Jondeau G; Meune C; Galinier M
    Ann Cardiol Angeiol (Paris); 2009 Jun; 58(3):165-79. PubMed ID: 19457468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-terminal-pro-brain natriuretic peptide, but not brain natriuretic peptide, is increased in patients with severe obesity.
    Fernandes F; Ramires FJ; Buck PC; Almeida IJ; Rabelo R; Dantas SA; Salemi VM; Halpern A; Mady C
    Braz J Med Biol Res; 2007 Feb; 40(2):153-8. PubMed ID: 17273651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery (Br J Surg 2005; 92: 1041-1045).
    Gibson S; Berry C; Kingsmore D
    Br J Surg; 2005 Nov; 92(11):1453-4. PubMed ID: 16237747
    [No Abstract]   [Full Text] [Related]  

  • 24. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery (Br J Surg 2005; 92: 1041-1045).
    Brady RR; Ryan M
    Br J Surg; 2005 Dec; 92(12):1566; author reply 1566. PubMed ID: 16308866
    [No Abstract]   [Full Text] [Related]  

  • 25. Standardization of cardiac markers.
    Apple FS
    Scand J Clin Lab Invest Suppl; 2005; 240():107-11. PubMed ID: 16112967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential clinical application of novel cardiac biomarkers for acute myocardial infarction.
    Nursalim A; Suryaatmadja M; Panggabean M
    Acta Med Indones; 2013 Jul; 45(3):240-50. PubMed ID: 24045397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical usefulness of an assay for measurement of circulating N-terminal pro-B-type natriuretic peptide concentration in dogs and cats with heart disease.
    Oyama MA; Boswood A; Connolly DJ; Ettinger SJ; Fox PR; Gordon SG; Rush JE; Sisson DD; Stepien RL; Wess G; Zannad F
    J Am Vet Med Assoc; 2013 Jul; 243(1):71-82. PubMed ID: 23786193
    [No Abstract]   [Full Text] [Related]  

  • 28. [Clinical significance of brain natriuretic peptide measurements].
    Chen SB
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):743. PubMed ID: 17229374
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased ventricular ectopic activity in relation to C-reactive protein, and NT-pro-brain natriuretic peptide in subjects with no apparent heart disease.
    Sajadieh A; Nielsen OW; Rasmussen V; Ole Hein H; Hansen JF
    Pacing Clin Electrophysiol; 2006 Nov; 29(11):1188-94. PubMed ID: 17100670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natriuretic peptides and cardiovascular events: more than a stretch.
    Konstam MA
    JAMA; 2007 Jan; 297(2):212-4. PubMed ID: 17213406
    [No Abstract]   [Full Text] [Related]  

  • 31. Genetic polymorphism of the type A human natriuretic peptide receptor (NPR-A) gene contributes to the interindividual variability in the BNP system.
    Weber M; Burian M; Dragutinovic I; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C; Geisslinger G
    Eur J Heart Fail; 2008 May; 10(5):482-9. PubMed ID: 18436476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New tests for heart disease: promise but no payoff. Three new blood tests designed to detect early heart disease aren't quite ready for prime time.
    Harv Heart Lett; 2005 Jul; 15(11):6--7. PubMed ID: 16149177
    [No Abstract]   [Full Text] [Related]  

  • 33. [Advances in clinical studies on brain natriuretic peptide and N-terminal pro-brain natriuretic peptide].
    Liu J; Luo XP
    Zhonghua Er Ke Za Zhi; 2004 May; 42(5):352-5. PubMed ID: 15189693
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of contractility and postloading in the intensive care unit].
    Ochagavía A; Zapata L; Carrillo A; Rodríguez A; Guerrero M; Ayuela JM
    Med Intensiva; 2012; 36(5):365-74. PubMed ID: 22482957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Plasma levels of N-terminal pro-brain natriuretic peptide in the critically ill: the right hormonal marker in the wrong patients?
    Heringlake M; Bahlmann L; Klaus S
    Chest; 2006 Jan; 129(1):212-3; author reply 213. PubMed ID: 16424437
    [No Abstract]   [Full Text] [Related]  

  • 36. BNP-guided therapy for heart failure.
    Piña IL; O'Connor C
    JAMA; 2009 Jan; 301(4):432-4. PubMed ID: 19176447
    [No Abstract]   [Full Text] [Related]  

  • 37. COPD and cardiac death: pressure (NT-proBNP), inflammation (CRP) or both?
    Colice GL
    Respiration; 2010; 79(5):353-4. PubMed ID: 20110653
    [No Abstract]   [Full Text] [Related]  

  • 38. Homocysteine predicts increased NT-pro-BNP through impaired fatty acid oxidation.
    Guéant Rodriguez RM; Spada R; Pooya S; Jeannesson E; Moreno Garcia MA; Anello G; Bosco P; Elia M; Romano A; Alberto JM; Juillière Y; Guéant JL
    Int J Cardiol; 2013 Aug; 167(3):768-75. PubMed ID: 22459404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Usefulness of NT-proBNP as a heart disease marker for late-stage elderly patients receiving home medical care].
    Kondo S; Kondo Y; Kitagawa C; Katsuta S; Suzuki M
    Gan To Kagaku Ryoho; 2011 Dec; 38 Suppl 1():3-4. PubMed ID: 22189303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New tests for heart disease.
    Johns Hopkins Med Lett Health After 50; 2005 Dec; 17(10):4-5. PubMed ID: 16435426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.